AC Immune SA
From Verify.Wiki
| |
AC Immune SA | |
---|---|
Type | Public |
Industry | Biotechnology |
Founded | 2003 |
Headquarters | Lausanne, Switzerland |
Key people | Andrea Pfeifer (Co-Founder & CEO), Jean-Fabien Monin (CFO), Andreas Muhs (CSO) [1] |
Investors | Dietmar Hopp |
Number of employees | 62 [2] |
AC Immune SA, a clinical stage Swiss-based biopharmaceutical company, focuses on neurodegenerative diseases with three product candidates in clinical trials. It designs, discovers, and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. The company’s technology platforms create antibodies, small molecules, and vaccines to address a broad spectrum of neurodegenerative indications. It offers its therapies to address Alzheimer disease and neurodegenerative diseases, such as Parkinson’s, Down syndrome, and glaucoma.
AC Immune SA was founded in 2003 and is based in Lausanne, Switzerland. [3]
Contents
History
Controversies
Top 5 Recent Tweets
Date | Author | Comment |
---|---|---|
February 07, 2023 | AC_Immune_SA | We are pleased to announce two new grants, one from the Michael J. Fox Foundation for Parkinson’s Research and one… https://t.co/fRgdXfkUDU |
February 03, 2023 | AlzheimerEurope | .@AC_Immune_SA announced initial interim safety and immunogenicity data from its ABATE Phase 1b/2 #clinicaltrial of… https://t.co/BqE2Ig810H |
February 02, 2023 | AC_Immune_SA | Join AC Immune’s CEO Dr. Andrea Pfeifer, on February 14th, for a Fireside chat at the SVB Securities Global Biophar… https://t.co/cIa2frTQRU |
January 30, 2023 | fundamentalsbot | AC Immune SA's quarterly revenue growth rate YoY of -11.10% ranked 3475 out of 5735 companies in our database.… https://t.co/ypzTvZMvwD |